Form 4 for CING Cingulate Inc.
Accepted 2026-02-10 00:00:00 ET · period of report 2026-02-06 · accession 0001493152-26-006027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-02-10 | 2026-02-06 | CING | Werth Peter J. | Dir | P - Purchase | $5.04 | +19.5K | 117.4K | +20% | +$98.1K |
| DI | 2026-02-10 | 2026-02-06 | CING | Werth Peter J. | Dir | P - Purchase | $0.1 | +15.6K | 15.6K | New | +$1,556 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-06 | P | A | 19,455 | $5.04 | 117,449 | I By Werth Family Investment Associates LLC | — | — | (F1) Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. (F2) Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 2 | Derivative | Warrant to Purchase Common Stock | 2026-02-06 | P | A | 15,564 | $0.1 | 15,564 | I By Werth Family Investment Associates LLC | $5.04 · — to — | 15,564 Common Stock | (F1) Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. (F2) Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F3) The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date. |